AxoGen, Inc. (NASDAQ:AXGN) marched up 49.33% compared to a 52-week low price of $14.13. The shares were last seen trading -5.13% lower, taking the closing price at $21.1 on 6/6/2019. At a recent session, the prices were hovering between $21 and $22.24. This company shares are 60.19% off its target price of $33.8 and the current market capitalization stands at $813.62M. The recent change has given its price a -3.63% deficit over SMA 50 and -62.88% deficit over its 52-week high. The stock witnessed -13.67% declines, 2.98% gains and -38.47% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found AXGN’s volatility during a week at 4.77% and during a month it has been found around 5.91%.

AxoGen, Inc. (AXGN) Top Holders

Institutional investors currently hold around $758 million or 86.9% in AXGN stock. Look at its top three institutional owners: Arrowmark Colorado Holdings Llc owns $80.44 million in AxoGen, Inc., which represents roughly 9.89% of the company’s market cap and approximately 10.61% of the institutional ownership. Similar statistics are true for the second largest owner, Essex Woodlands Management, Inc., which owns 2,739,751 shares of the stock are valued at $60.93 million. The third largest holder is Blackrock Inc., which currently holds $54.83 million worth of this stock and that ownership represents nearly 6.74% of its market capitalization.

AxoGen, Inc. 13F Filings

At the end of March reporting period, 76 institutional holders increased their position in AxoGen, Inc. (NASDAQ:AXGN) by some 8,410,735 shares, 81 decreased positions by 9,139,121 and 23 held positions by 16,540,272. That puts total institutional holdings at 34,090,128 shares, according to SEC filings. The stock grabbed 34 new institutional investments totaling 2,869,069 shares while 36 institutional investors sold out their entire positions totaling 3,627,678 shares.

AxoGen, Inc. (NASDAQ:AXGN) Insider Trades

Multiple company employees have indulged in significant insider trading. AxoGen, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that VP Finance & Treasurer Hansen David K has sold 20,000 shares of AxoGen, Inc. (AXGN) in the trading session dated May. 13, 2019. These shares are worth $452,600 and were traded at $22.63 each. The SEC filing shows that Freitag Gregory Gene performed a sale of 45,000 shares. The General Counsel disposed these shares by way of transaction on Nov. 30, 2018. The company’s shares were given away at $33 per share worth to an income of some $1,485,000 to the account of Freitag Gregory Gene.

General Counsel, Freitag Gregory Gene, sold 20,000 common shares of AxoGen, Inc. (AXGN) in the open market. In a transaction dated Nov. 15, 2018, the shares were put up for sale at an average price of $32.25, raking in a sum of $645,000. After this sale, 140,865 common shares of AXGN are directly owned by the insider, with total stake valued at $2,972,252.

In the transaction dated Nov. 14, 2018, a great number of shares sold came courtesy the CEO; Zaderej Karen L. disposed a total of 25,000 shares at an average price of $33.18, amounting to approximately $829,500. The insider now directly owns 382,970 shares worth $8,080,667.

AxoGen, Inc. (AXGN) Analyst Guide

Several analysts have released their opinion on AxoGen, Inc. (NASDAQ:AXGN), with 4 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 2 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.33 average brokerage recommendation [T1].